Gapping up
In reaction to strong earnings/guidance: ROCK +39.9%, GLOB +16.9%, TVPT +14.4%, LDRH +10.7%, BRCD +8.3%,NVDA +8.2%, GOGL +8%, SNPS +6.6%, SODA +5.2%, SPWR +5.1%, SPRT +5%, UFPI +5%, EPAM +5%, CLD +4.9%,KEG +4.7%, AAN +4.7%, NGD +3.9%, MPEL +3.5%, WPZ +3.3%, JIVE +2.5%, MZOR +2.4%, MFA +2.3%, LZB +1.9%,UGP +1.9%, DNR +1.8%, KNOP +1.7%, COT +1.5%, GPOR +1.2%, CBMX +1.2%, CPA +0.9%, TNK +0.9%, NVMI+0.7%, SIX +0.7%, CBR +0.7%
M&A news: IM +23.2% (Ingram Micro enters into agreement to be acquired by Tianjin Tianhai for $38.90/share to become a part of HNA Group)
Select oil/gas related names showing strength: SDRL +2.7%, KMI +2.3%, COP +1.7%, BP +1.7%, CHK +1.6%
Other news: ATHX +30.3% (reported 1 year results from phase 2 stroke study of MultiStem Cell Therapy demonstrate a significantly higher rate of complete or nearly full recovery), ZFGN +19.6% (Phase 2b Trial of Beloranib in severe obesity complicated by type 2 diabetes achieves primary efficacy endpoint), AERI +16.6% ( reports 'successful' 12-month interim safety results of Phase 3 registration trial for Rhopressa), ANAD +8.6% (declares a competing bidder's proposal to acquire the co for $0.78/share a 'superior offer' to the previously announced offer of $0.66/share), PETX +8.3% (has filed a Marketing Authorization Application with the European Medicines Agency for GALLIPRANT), PTLA +5% (Biologics License Application for Andexanet Alfa accepted for review by FDA), MRVL +4.3% (Co and Carnegie Mellon University have settled their patent infringement lawsuit; MRVL to pay $750 mln to university), GLUU +4.2% ('Kendall and Kylie' game is #1 among free apps in Apple's app store), FCX +3.5% (cont strength), TSLA +3% (still checking), GWPH +2.9% (still checking), GPRO+2.3% (still checking), YHOO +1.9% (Activist investor Starboard working to launch a potential proxy fight with Yahoo, according to Bloomberg), BABA +0.8% (in symp with YHOO)
Analyst comments: IBM +2.7% (upgraded to Overweight from Equal-Weight at Morgan Stanley), AMZN +1.4% (upgraded to Buy from Hold at Canaccord Genuity)
In reaction to strong earnings/guidance: ROCK +39.9%, GLOB +16.9%, TVPT +14.4%, LDRH +10.7%, BRCD +8.3%,NVDA +8.2%, GOGL +8%, SNPS +6.6%, SODA +5.2%, SPWR +5.1%, SPRT +5%, UFPI +5%, EPAM +5%, CLD +4.9%,KEG +4.7%, AAN +4.7%, NGD +3.9%, MPEL +3.5%, WPZ +3.3%, JIVE +2.5%, MZOR +2.4%, MFA +2.3%, LZB +1.9%,UGP +1.9%, DNR +1.8%, KNOP +1.7%, COT +1.5%, GPOR +1.2%, CBMX +1.2%, CPA +0.9%, TNK +0.9%, NVMI+0.7%, SIX +0.7%, CBR +0.7%
M&A news: IM +23.2% (Ingram Micro enters into agreement to be acquired by Tianjin Tianhai for $38.90/share to become a part of HNA Group)
Select oil/gas related names showing strength: SDRL +2.7%, KMI +2.3%, COP +1.7%, BP +1.7%, CHK +1.6%
Other news: ATHX +30.3% (reported 1 year results from phase 2 stroke study of MultiStem Cell Therapy demonstrate a significantly higher rate of complete or nearly full recovery), ZFGN +19.6% (Phase 2b Trial of Beloranib in severe obesity complicated by type 2 diabetes achieves primary efficacy endpoint), AERI +16.6% ( reports 'successful' 12-month interim safety results of Phase 3 registration trial for Rhopressa), ANAD +8.6% (declares a competing bidder's proposal to acquire the co for $0.78/share a 'superior offer' to the previously announced offer of $0.66/share), PETX +8.3% (has filed a Marketing Authorization Application with the European Medicines Agency for GALLIPRANT), PTLA +5% (Biologics License Application for Andexanet Alfa accepted for review by FDA), MRVL +4.3% (Co and Carnegie Mellon University have settled their patent infringement lawsuit; MRVL to pay $750 mln to university), GLUU +4.2% ('Kendall and Kylie' game is #1 among free apps in Apple's app store), FCX +3.5% (cont strength), TSLA +3% (still checking), GWPH +2.9% (still checking), GPRO+2.3% (still checking), YHOO +1.9% (Activist investor Starboard working to launch a potential proxy fight with Yahoo, according to Bloomberg), BABA +0.8% (in symp with YHOO)
Analyst comments: IBM +2.7% (upgraded to Overweight from Equal-Weight at Morgan Stanley), AMZN +1.4% (upgraded to Buy from Hold at Canaccord Genuity)